The Boston Beer Company (SAM)
(Delayed Data from NYSE)
$296.65 USD
+1.71 (0.58%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $296.96 +0.31 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$296.65 USD
+1.71 (0.58%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $296.96 +0.31 (0.10%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Zacks News
Is a Surprise Coming for Boston Beer (SAM) This Earnings Season?
by Zacks Equity Research
Boston Beer (SAM) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will Archer Daniels' (ADM) Strategic Efforts Aid Q2 Earnings?
by Zacks Equity Research
Archer Daniels (ADM) looks promising on the back of its portfolio management initiatives, cost-savings plan and Readiness program. These initiatives are likely to drive second-quarter 2018 results.
Will Robust Strategies Fuel Colgate's (CL) Q2 Earnings?
by Zacks Equity Research
Colgate (CL) is encouraged with its savings program along with brand building and productivity maximization initiatives. These, in turn, are likely to drive second-quarter 2018 results.
Zacks.com highlights: lululemon athletica, Perry Ellis International, Boston Beer Company, Medifast and Navigators Group
by Zacks Equity Research
Zacks.com highlights: lululemon athletica, Perry Ellis International, Boston Beer Company, Medifast and Navigators Group
Can FEMSA's (FMX) Efforts Aid Earnings Trend Reversal in Q2?
by Zacks Equity Research
FEMSA (FMX) witnesses mixed sentiments as investors are concerned about its dismal surprise history while its strategic initiatives reflect potential.
Buy These 5 Low-Beta Stocks to Tackle Volatility Woes
by Zacks Equity Research
We create a strategy that promises handsome returns from less-risky stocks if some parameters are taken into account.
Will Global Segment Drive Lamb Weston (LW) in Q4 Earnings?
by Zacks Equity Research
Aggressive pricing actions, solid performance in global segment and LTO innovations are likely to drive Lamb Weston's (LW) fourth quarter results.
Boston Beer, Keurig Dr Pepper and Microsoft highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Boston Beer, Keurig Dr Pepper and Microsoft highlighted as Zacks Bull and Bear of the Day
Bull of the Day: The Boston Beer Company (SAM)
by Brian Hamilton
EPS is expected to grow by +17.9% in its upcoming earnings report.
Factors Setting the Tone for AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev's (BUD) dismal earnings trend and the volatility in certain key markets are concerns for its second-quarter results. However, a positive overall outlook and the brand strength infuse optimism.
Improving Depletions to Aid Boston Beer's (SAM) Q2 Earnings
by Zacks Equity Research
Boston Beer (SAM) is positioned to gain from its robust brands' portfolio, pricing and product innovations. Favorable depletion trends from new launches are likely to drive second-quarter results.
Factors Setting the Tone for Coca-Cola's (KO) Q2 Earnings
by Zacks Equity Research
Coca-Cola (KO) is witnessing a year-over-year decline in revenues for the last few quarters, primarily due to weak volumes and structural headwinds.
Can Savings Keep Kimberly-Clark (KMB) Afloat in Q2 Earnings?
by Zacks Equity Research
Kimberly-Clark (KMB) struggles with higher commodity costs and lower selling prices. However, robust cost reduction efforts are likely to aid performance in Q2.
Boston Beer at a 52-Week High: An Insight into the Catalysts
by Zacks Equity Research
Boston Beer's (SAM) cost saving and brand innovation initiatives will boost operating performance of the stock amid stiff competition.
Top Ranked Momentum Stocks to Buy for July 17th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th:
Brown-Forman's New Buyback Plan to Boost Shareholder Returns
by Zacks Equity Research
Brown-Forman (BF.B) rewards shareholders by authorizing a $200-million share repurchase program, which extends for a year.
Top Ranked Momentum Stocks to Buy for July 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 16th:
Church & Dwight Hits 52-Week High: Is There More Room to Run?
by Zacks Equity Research
Strength in Church & Dwight's (CHD) International Consumer unit and consistent organic sales growth is likely to offset margin pressure.
Constellation Brands Buys Four Corners, Adds Beer Flavors
by Zacks Equity Research
Constellation Brands (STZ) acquires Four Corners to maintain its strong position in the beer space. The company is in the third spot in the high-end U.S. beer industry.
Anatomy of Success: Boston Beer Company (SAM)
by Ryan McQueeney
If investors had followed our ranking system when it flagged this iconic beer brand, they would have witnessed massive profits.
How is Boston Beer (SAM) Placed in the Craft Beer Space?
by Zacks Equity Research
Boston Beer's (SAM) three-point growth plan, focused on the revival of Samuel Adams and Angry Orchard brands, cost savings and product innovation, is driving the stock.
Are Healthier Options Making the Craft Beer Market Suffer?
by Ritujay Ghosh
Millennials are opting for healthier and non-alcoholic drinks, which has made not only soft beverages companies shift focus toward healthier drinks, but also beer manufacturers reorient their product line with low-alcohol content.
Can Colgate's (CL) Growth Strategies Help Regain Momentum?
by Zacks Equity Research
Colgate's (CL) long-term strategies and earnings trend reflect fundamental strength, positioning it for growth. However, soft-margin trend remains a deterrent.
Will Brown-Forman's (BF.B) Shares Continue to Trend Higher?
by Zacks Equity Research
Brown-Forman (BF.B) gains from impressive surprise history, solid brand portfolio, expansion plans and shareholder-friendly moves. Rise in Jack Daniel's prices in Europe may hurt the top line.
Why Ambev (ABEV) Could Be Positioned for a Slump
by Zacks Equity Research
Ambev (ABEV) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.